Is Signposting to Online Peer Support Helpful in Decreasing Loneliness in Parents of Children With Long-term Conditions and Disabilities?

September 11, 2023 updated by: University College, London

Is Signposting to Online Peer Support Helpful in Decreasing Loneliness in Parents of Children With Long-term Conditions and Disabilities? A Randomised Controlled Trial

The present study aims to evaluate whether signposting to online peer support will be associated with a significant decrease in self-reported loneliness for parents of children with long-term conditions and disabilities. Parents of children with long-term conditions and disabilities will be randomised to either the treatment condition, being signposted to online peer support, or to the waitlist condition. Whether signposting to online peer support has an impact on social capital and anxiety and depression will also be investigated.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Loneliness has been defined as an aversive subjective experience that occurs when a person's social network is lacking in either quality or quantity compared to their needs. A recent poll of 2000 parents found that more than half had experienced a problem with loneliness.

There is ample evidence that parental loneliness has negative consequences for both the parent and child. Loneliness has been associated with parental stress, with maternal loneliness being associated with dissatisfaction with life and the couple relationship and depressive symptoms, and found to be a predictor of chronic depression. Paternal loneliness has been shown to predict son's loneliness, and daughter's loneliness is predicted by maternal loneliness. Additionally, maternal loneliness has been found to predict social competence and fear of negative evaluation in adolescents.

Social capital, which has been defined as the creation of personal relationships and the benefits that come with them, has been found to be significantly inversely associated with loneliness in different populations, for example older adults and students.

A recent scoping review found that parents of children with long-term conditions or disabilities appear to be at increased risk of loneliness, but there has been little research looking directly at what might help to alleviate loneliness in this group. The review identified that peer support could be a potential key mechanism in reducing loneliness in parents.

With stretched mental health services for families in the UK, parents are often signposted to peer support groups for advice and support. Due to the COVID-19 pandemic many face-to-face peer support groups have been forced to close, with signposting options being limited to online peer support groups or forums.

The primary aim of the study is to evaluate the effectiveness of signposting parents of children with long-term conditions and disabilities to peer support groups in terms of alleviating loneliness (relative to a wait list control). A secondary aim is to identify the predictors of such change / any response to allocation to the peer support groups, including attendance of the peer support and changes in online and offline social capital. Whether signposting to online peer support has an impact on anxiety and depression will also be investigated.

Study Type

Interventional

Enrollment (Actual)

83

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • London, United Kingdom, WC1H 0BT
        • University College, London

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

14 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion criteria:

  • participants will be required to have one or more child with long-term conditions or disabilities
  • participants must consent to take part
  • participants should be sufficiently fluent in English to enable participation in online peer support groups and forums as well as participation in the study.

Exclusion criteria:

- participants must not be under 18 years of age.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention condition - signposting to online peer support
The intervention group will be sent a list of online peer support signposting groups and forums to engage with, which will be adapted depending on what health conditions their child has. They will be asked to keep a weekly engagement log for three months.
Signposting to online peer support groups and forums
No Intervention: Waitlist condition
The waitlist group will be informed that they will be contacted again in three months, after which, the waitlist will be sent the signposting resources.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Loneliness
Time Frame: Measured at baseline (time 1), post (3 months - time 2), follow up (6 months - time 3)
Change in self-reported loneliness on the 20-item revised UCLA Loneliness Scale (R-UCLA: Russell, Peplau, & Cutrona, 1980). Scores range from 20 to 80, with higher scores indicating a higher level of self-reported loneliness.
Measured at baseline (time 1), post (3 months - time 2), follow up (6 months - time 3)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Social Capital
Time Frame: Measured at baseline (time 1), post (3 months - time 2), follow up (6 months - time 3)
Change in self-reported social capital (online and offline) on the Williams' (2006) Internet Social Capital scale. Scores range from 10 to 50 on each subscale (online and offline), with higher scores indicating a higher level of self-reported social capital
Measured at baseline (time 1), post (3 months - time 2), follow up (6 months - time 3)
Anxiety and Depression
Time Frame: Measured at baseline (time 1), post (3 months - time 2), follow up (6 months - time 3)
Change in self-reported anxiety and depression on the Hospital Anxiety and Depression Scale (Zigmond & Snaith, 1983). Scores range from 0-21 on each subscale (depression and anxiety), with higher scores indicating a higher level of self-reported anxiety or depression symptoms.
Measured at baseline (time 1), post (3 months - time 2), follow up (6 months - time 3)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Sophie Bennett, University College, London

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 7, 2022

Primary Completion (Actual)

August 31, 2023

Study Completion (Actual)

August 31, 2023

Study Registration Dates

First Submitted

May 9, 2022

First Submitted That Met QC Criteria

May 9, 2022

First Posted (Actual)

May 13, 2022

Study Record Updates

Last Update Posted (Actual)

September 13, 2023

Last Update Submitted That Met QC Criteria

September 11, 2023

Last Verified

September 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Anonymised data will be stored indefinitely on a secure UCL database and may be used for future research, it will not be identifiable to you in any way.

IPD Sharing Access Criteria

Data will be available on reasonable request

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ICF
  • ANALYTIC_CODE
  • CSR

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Depression

Clinical Trials on Online Peer Support

Subscribe